Patient-driven Insights Into the Impact of COVID-19 on the Rare Disease Community

Learn the Ways Pharma Can Empower Rare Disease Patients During the Uncertainty of the COVID-19 Pandemic

Xperiome, a global healthtech company specializing in rare disease, and Magnolia Innovation, partnered up to explore how COVID-19 has impacted the rare disease community, including changes in patient and caregiver behaviors and the emotional toll of the pandemic.